Jerusalem Post: Israeli co. kicks off COVID oral vaccine trial in South Africa

The first volunteer in a Phase I clinical trial of an oral COVID-19 vaccine developed by an Israeli-American company has been screened and enrolled, according to Oravax Medical, a subsidiary of Oramed Pharmaceuticals.
The trial is taking place in South Africa. Read more here.

You may also be interested

Join our mailing list

Skip to content